Alsakali Equity AB

Insider profile

Performance

Overall performance
2.3

Performance over holding periods
2.3
30 days 90 days 120 days
Average return -5% 8.2% 15.1%
Success rate 42% 68% 82%
Transactions
12 100% Buy
34 71% Buy
47 69% Buy
Alsakali Equity AB's trades of Newbury Pharmaceuticals AB's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2025-11-18 2025-11-18 B Purchase
74,146
364.87
SEK3,927,684
74,146 364.87 SEK3,927,684
2025-11-17 2025-11-17 B Purchase
22,714
471.11
SEK1,404,837
22,714 471.11 SEK1,404,837
2025-11-12 2025-11-12 B Purchase
48,973
397.29
SEK2,726,735
48,973 397.29 SEK2,726,735
2024-01-25 2024-01-25 B Purchase
7,000
4.78
SEK33,460
7,000 4.78 SEK33,460
2024-01-23 2024-01-23 B Purchase
4,000
4.84
SEK19,360
4,000 4.84 SEK19,360
2024-01-22 2024-01-22 B Purchase
4,000
4.73
SEK18,920
4,000 4.73 SEK18,920
2024-01-16 2024-01-16 B Purchase
6,000
3.75
SEK22,500
6,000 3.75 SEK22,500
2024-01-12 2024-01-12 B Purchase
7,000
3.84
SEK26,880
7,000 3.84 SEK26,880
2024-01-11 2024-01-11 B Purchase
9,750,000
0.36
SEK3,510,000
9,750,000 0.36 SEK3,510,000
2023-10-30 2023-10-30 B Purchase
2,500
3.86
SEK9,650
2,500 3.86 SEK9,650
2023-10-30 2023-10-30 B Purchase
30,000
3.43
SEK102,900
30,000 3.43 SEK102,900
2023-04-12 2023-04-12 B Purchase
5,000
5.28
SEK26,420
5,000 5.28 SEK26,420
2022-02-14 2022-02-14 B Purchase
2,000
9.54
SEK19,080
2,000 9.54 SEK19,080